Glenmark in talks to sell up to 30% in API biz to PremjiInvest

The pharma group plans to sell minority stake for $150m in their new subsidiary of active pharmaceutical ingredient products. Discussions are ongoing with True North

from Industry-Economic Times
Read The Rest:economictimes...